Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis. Baghdad Science Journal, Iraq, Baghdad, v. 19, n. 6, p. 1191, 2022. DOI: 10.21123/bsj.2022.6431. Disponível em: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/6431.. Acesso em: 1 sep. 2024.